Autolus Therapeutics plc American Depositary Share (AUTL) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Autolus Therapeutics plc American Depositary Share, updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Autolus Therapeutics plc American Depositary Share (AUTL) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $413M. It trades at $1.63, up 5.16% today. Its overall quality score is 31 out of 100, ranked against the whole US market. 4 analysts' average target of $7.70 implies +372.4% from today's price. Kronos AI's 30-day forecast is +5.1% (6 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $7.70 |
| Low – high | $5.00 – $10.00 |
| Analysts | 4 |
| Upside to average | +372.4% |
Kronos AI 30-day forecast
| Expected close | $1.63 (+5.1%) |
| Likely range | −1.7% … +10.7% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 8 |
| Solvency | 15 |
| Growth | 71 |
| Overall | 31 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |